1. Arango D, Augenlicht LH (2001) New approaches to colorectal cancer treatment. In Recent Research Developments in Cancer, Vol. 3 pp 385–395. Trivandrum: Transworld Research Network
2. Arango D, Corner GA, Wadler S, Catalano PJ, Augenlicht LH (2001) c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. Cancer Res 61: 4910–4915
3. Arango D, Wilson AJ, Mariadason JM, Corner GA, Arañes MJ, Nicholas C, Augenlicht LH (2003) Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. (submitted)
4. Augenlicht LH, Wadler S, Corner G, Richards C, Ryan L, Multani AS, Pathak S, Benson A, Haller D, Heerdt BG (1997) Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res 57: 1769–1775
5. Augeron C, Laboisse CL (1984) Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44: 3961–3969